logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울행정법원 2019.03.21 2018구합3059
요양기관 업무정지처분취소
Text

1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

Reasons

A. A claim for medical care benefit costs (3,985,10 won) and medical care benefit costs (3,322,470 won) is made by issuing an out-of-the-counter prescription as medical care benefit costs and claiming pharmacy medication costs (hereinafter “instant ground for disposition”): 2,803,60 won for health insurance action and the list of non-benefit benefits and the relative point of relative value of benefits (a-1-b) No. 1 of Part II, Chapter 1, Chapter 1, Part II, Chapter 5, Chapter 5, and Chapter 7. (a-1-b) of the National Funds Act (i.e., medical care costs) (i., medical care costs) (i., the patient’s family members did not directly request the treatment of the patient, and (ii) the patient’s family members received or were issued only after consultation with the doctor in charge, but the difference between the patient’s medical care benefit costs and the medical treatment fees (i.e., the medical treatment costs) shall be calculated by 50% for the medical care benefit costs).

E. Specific details of the calculation of the period of business suspension are as follows.

The fact that 343,430,690, 110, 370 won 10, 505, 518 won 2.94% / 30% of the total amount of costs of health care benefit in the investigation period (including the number of pages; hereinafter the same shall apply) from September 2012 to June 2015 to August 2015, 2015, the average amount of the unfair monthly unfair amount was suspended, and 343,430,690 won / 10,110,370 won 505,518 won 2.94% of the total amount of costs of health care benefit in the investigation period, Gap

2. Whether the instant disposition is lawful

A. Facts of recognition 1) Article 9 of the Rules on the Standards for Medical Care Benefits under National Health Insurance at the time of the instant on-site verification [Attachment 2] 1.

(b) Medical care benefit benefits shall be paid to the relevant skin disease according to the skin disease, such as a sloping, multiple-one-yearm, single-magn, magnosis, magnopia, magropium, magropium, and pule phenomenon;

arrow